Browsing by Author Mesía Nin, Ricard
Showing results 4 to 23 of 32
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 24-Jan-2022 | Defining a standard set of health outcomes for patients with squamous cell carcinoma of the head and neck in Spain | Arrazubi, Virginia; Cajaraville, Gerardo; Cantero, David; Giralt, Jordi; Mesía Nin, Ricard; Monje, Florencio; Rueda, Antonio; Sistiaga, Alexander; Suarez, Jorge; Mut, Alejandro; Comellas, Marta; Lizán, Luis |
| 1-Mar-2018 | Double positivity for HPV-DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients | Mena Cervigón, Marisa; Taberna, Miren; Tous, Sara; Clavero, Omar; Quiros, Beatriz; Lloveras Rubio, Betlem; Alejo, Maria; Leon, Xavier; Quer, Miquel; Bague, Silvia; Mesía Nin, Ricard; Nogues, Julio; Gomà, Montse; Aguilà, Anton; Bonfill, Teresa; Blazquez, Carmen; Guix, Marta; Hijano, Rafael; Torres, Montserrat; Holzinger, Dana; Pawlita, Michael; Pavón Ribas, Miquel Àngel; Bravo, Ignacio G.; Sanjosé Llongueras, Silvia de; Bosch José, Francesc Xavier, 1947-; Alemany i Vilches, Laia; Marquez, Sandra |
| 1-Jan-2019 | Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with >= 25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy | Zandberg, Dan P.; Algazi, Alain P.; Jimeno, Antonio; Good, James S.; Fayette, Jérôme; Bouganim, Nathaniel; Ready, Neal E.; Clement, Paul M.; Even, Caroline; Jang, Raymond W.; Wong, Stuart; Keilholz, Ulrich; Gilbert, Jill; Fenton, Moon; Brana, Irene; Henry, Stephanie; Remenar, Eva; Papai, Zsuzsanna; Siu, Lillian L.; Jarkowski, Anthony; Armstrong, Jon M.; Asubonteng, Kobby; Fan, Jean; Melillo, Giovanni; Mesía Nin, Ricard |
| 1-Jul-2020 | Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open -label phase III study | Ferris, R. L.; Haddad, R.; Even, C.; Tahara, Makoto; Dvorkin, M.; Ciuleanu, T. E.; Clement, Paul M.; Mesía Nin, Ricard; Kutukova, S.; Zholudeva, L.; Daste, Amaury; Caballero Daroqui, Javier; Keam, B.; Vynnychenko, I.; Lafond, C.; Shetty, J.; Mann, H.; Fan, Jean; Wildsmith, S.; Morsli, N.; Fayette, J.; Licitra, L. |
| 6-Aug-2020 | Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe | Mena Cervigón, Marisa; Frias Gomez, Jon; Taberna, Miren; Quirós, Beatriz; Marquez, Sandra; Clavero, Omar; Baena, A.; Lloveras Rubio, Betlem; Alejo, Maria; León, X.; García, J.; Mesía Nin, Ricard; Bermejo, O.; Bonfill, T.; Aguilà, Anton; Guix, M.; Hijano, R.; Pavón Ribas, Miquel Àngel; Torres, M.; Tous, Sara; Clèries Soler, Ramon; Alemany i Vilches, Laia |
| 1-Apr-2019 | Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population | Fernández Mateos, Javier; Seijas Tamayo, Raquel; Adansa Klain, Juan Carlos; Pastor Borgoñón, Miguel; Pérez Ruiz, Elisabeth; Mesía Nin, Ricard; Barco, Elvira del; Salvador Coloma, Carmen; Rueda Dominguez, Antonio; Caballero Daroqui, Javier; Fernández Ruiz, Encarnación; Ocana, Alberto; González Sarmiento, Rogelio; Cruz Hernández, Juan Jesús |
| 17-Apr-2018 | Hpv-relatedness Definitions For Classifying Hpv-related Oropharyngeal Cancer Patient Do Impact On Tnm Classification And Patients' Survival | Taberna, Miren; Mena Cervigón, Marisa; Tous, Sara; Pavón Ribas, Miquel Àngel; Oliva, Marc; León, Xavier; Garcia, Jacinto; Guix, Marta; Hijano, Rafael; Bonfill, Teresa; Aguilà, Anton; Alemany i Vilches, Laia; Mesía Nin, Ricard |
| 1-Jan-2019 | Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma | Oliva, Marc; Spreafico, Anna; Taberna, Miren; Alemany i Vilches, Laia; Coburn, Bryan; Mesía Nin, Ricard; Siu, Lillian L. |
| 10-Dec-2014 | Introducción de Cetuximab en el tratamiento del carcinoma escamoso de cabeza y cuello | Mesía Nin, Ricard |
| 27-Jan-2022 | Modulation of DNA damage response by SAM and HD Domain containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) determines prognosis and treatment efficacy in different solid tumor types | Felip, Eudald; Gutiérrez-Chamorro, Lucía; Gómez, Maica; Garcia-Vidal, Edurne; Romeo, Margarita; Morán, Teresa; Layos, Laura; Pérez-Roca, Laia; Riveira-Muñoz, Eva; Clotet, Bonaventura, 1953-; Fernández, Pedro Luis; Mesía Nin, Ricard; Martínez Cardús, Anna; Ballana, Ester; Margelí Vila, Mireia |
| 30-Jun-2022 | Nutritional and body composition changes affecting head and neck cancer patients during oncological treatment | Arribas Hortigüela, Lorena |
| 6-Oct-2020 | Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial | Fernández Mateos, Javier; Pérez García, Jéssica; Seijas Tamayo, Raquel; Mesía Nin, Ricard; Rubió Casadevall, Jordi; García Girón, Carlos; Iglesias, Lara; Carral Maseda, Alberto; Adansa Klain, Juan Carlos; Taberna, Miren; Vazquez, Silvia; Gómez, María Asunción; Barco, Edel del; Ocana, Alberto; González Sarmiento, Rogelio; Cruz Hernández, Juan Jesús |
| 22-Jul-2022 | Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy | Marín Jiménez, Juan A.; Oliva, Marc; Peinado Martín, Paloma; Cabezas Camarero, Santiago; Plana Serrahima, Maria; Vázquez Masedo, Gonzalo; Lozano Borbalas, Alicia; Cabrera Martín, María N.; Esteve, Anna; Iglesias Moreno, María C.; Vilajosana Altamis, Esther; Arribas Hortigüela, Lorena; Taberna, Miren; Pérez Segura, Pedro; Mesía Nin, Ricard |
| May-2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 | Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; González Mendoza, René; Jia, Liyi; Chirovsky, Diana; Norquist, Josephine; Jin, Fan; Burtness, Barbara |
| 1-May-2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048 | Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; Gonzalez Mendoza, René; Jia, Liyi; Chirovsky, Diana; Norquist, Josephine; Jin, Fan; Burtness, Barbara |
| 20-Jul-2022 | Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score | Burtness, Barbara; Rischin, Danny; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Ge, Joy; Swaby, Ramona F.; Gumuscu, Burak; Harrington, Kevin J. |
| 11-Oct-2022 | Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study | Harrington, Kevin J.; Burtness, Barbara; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Lin, Jiaxin; Gumuscu, Burak; Swaby, Ramona F.; Rischin, Danny |
| 25-Jun-2021 | Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors | Arribas, Lorena; Plana, Maria; Taberna, Miren; Sospedra, Maria; Vilariño, Noelia; Oliva, Marc; Pallarés, Natàlia; González Tampán, Ana Regina; Rio, Luis Miguel del; Mesía Nin, Ricard; Baracos, Vickie |
| 9-Jan-2024 | Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience | Fontanals Martínez, Sandra; Esteve, Anna; González, Andrea; Ibáñez, Cristina; Mesía Nin, Ricard; Clopés Estela, Ana |
| 1-Feb-2019 | Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC The Phase 2 CONDOR Randomized Clinical Trial | Siu, Lillian L.; Even, Caroline; Mesía Nin, Ricard; Remenar, Eva; Daste, Amaury; Delord, Jean-Pierre; Krauss, Jürgen; Saba, Nabil F.; Nabell, Lisle; Ready, Neal E.; Brana, Irene; Kotecki, Nuria; Zandberg, Dan P.; Gilbert, Jill; Mehanna, Hisham; Bonomi, Marcelo; Jarkowski, Anthony; Melillo, Giovanni; Armstrong, Jon M.; Wildsmith, Sophie; Fayette, Jérôme |